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Abstract Sphingomyelinase (SMase) and ceramidase (CDase)
activities participate in sphingomyelin (SM) metabolism and
have a role in the signal transduction of a variety of ligands. In
this study evidence is presented that caveolin-enriched light
membranes (CELMs) of murine endothelial cells, characterized
by high SM, ceramide (Cer) and cholesterol content, bear acid
and neutral SMase as well as neutral CDase activities.
Localization of neutral CDase in CELMs was confirmed by
Western analysis. Notably, cell treatment with cyclodextrin,
which depleted cell cholesterol, did not affect acid or neutral
SMase activities but significantly enhanced neutral CDase
activity in CELMs, indicating a negative role for cholesterol in
CDase regulation. These findings suggest that neutral CDase is
implicated, together with SMase activities, in the control of
caveolar Cer content that may be critical for caveola
dynamics. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Extensive work performed over the last decade has high-
lighted the role of sphingolipids and their metabolites as bio-
modulators of multiple cell functions [1,2]. Various ligands are
known to elicit their biological responses through the signal-
ing pathway generated by the sphingomyelinase (SMase)-cat-
alyzed hydrolysis of sphingomyelin (SM), that generates cer-
amide (Cer) and phosphocholine [2,3]. Cer, backbone of all
sphingolipids, has been shown to be involved in the regulation
of multiple biological processes including cell di¡erentiation
and apoptosis [3,4]. Ceramidases (CDases) are enzymes that
hydrolyze the N-acyl linkage of Cer into sphingosine (Sph)
and free fatty acid. Current knowledge indicates that Sph is
not produced by de novo synthesis [5], thus crucially implicat-
ing CDase not only in the turn-o¡ of Cer-induced signaling
pathways but also in the formation of Sph, which can be
phosphorylated to Sph 1-phosphate (S1P) by Sph kinase. No-
tably, S1P, which acts as extracellular ligand as well as an
intracellular mediator, is recognized to exert powerful biolog-
ical actions including mitogenic and antiapoptotic e¡ects in a
number of cell types [6]. Similarly to what is observed for
SMase, multiple isoforms of CDase have been reported,
mainly di¡ering by their catalytic pH optima. Molecular clon-
ing of neutral CDase recently performed in mouse [7], human
[8] and rat [9] has shown the occurrence of at least three
distinct membrane-bound isoforms, which may also di¡er
for subcellular localization.
Caveolae are £ask-shaped invaginations of the plasma
membrane coated by a 22 kDa structural protein denomi-
nated caveolin (cav) [10], initially detected in endothelial cells
and successively individuated in many cell types. Such micro-
domains are highly enriched in SM and cholesterol [11,12] and
are distinguishable from bulk cellular membranes by their re-
sistance to detergent solubilization [13]. Caveolae have been
implicated in a wide range of cellular functions including
transcytosis, receptor-mediated uptake, stabilization of lipid
rafts and compartmentalization of a number of signaling
events at the cell surface [11^13]. Remarkably, approximately
half of cellular Cer appears to be located in sphingolipid-en-
riched domains [14,15] and, on the basis of profound changes
in the biophysical properties of membranes induced by in-
creases of Cer in membrane bilayers, an active function of
Cer in raft organization and tra⁄cking has been proposed
[16]. Intriguingly, increase of Cer in caveolar microdomains
was found to be elicited by interleukin 1L [14] and nerve
growth factor [17] supporting the view that Cer content of
caveolar microdomains could be regulated by extracellular
signals. Consistent with these ¢ndings, acid SMase was de-
tected in caveolae fractions of human ¢broblasts [14] and
very recently neutral and acid SMases were both identi¢ed
in sphingolipid-enriched domains of the same cell type [18].
However, at present it is not known whether Cer localized in
caveolae can be further metabolized to Sph in these micro-
domains. In view of the scarce propensity of Cer to interbi-
layer movements [19], this issue could be of importance in the
comprehension of the mechanisms involved in the regulation
of the lipid membrane content. In this study we present evi-
dence that neutral CDase resides in cav-enriched light mem-
branes (CELMs) of murine endothelial cells, together with
acid and neutral SMase activities. Of note, exclusively neutral
CDase activity resulted to be positively modulated upon cho-
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lesterol depletion, suggesting that the regulation of enzyme
speci¢cally depends on membrane cholesterol levels.
2. Materials and methods
2.1. Materials
H.end.FB murine endothelial cells were a kind gift of Prof. F.
Bussolino (University of Turin, Turin, Italy). [3H]Palmitic acid (30^
60 Ci/mmol) and [3H]acetic acid (2^5 Ci/mmol) were purchased from
Du Pont NEN (Boston, MA, USA). Reagents, materials for cell cul-
tures, cyclodextrin (CD) were obtained from Sigma (St. Louis, MO,
USA). BODIPY FL-SM and BODIPY FL-Cer were obtained from
Molecular Probes (Leiden, The Netherlands). C12-NBD-Cer was pre-
pared by the method described in [20]. Precoated silica gel 60 thin
layer chromatography (TLC) plates were obtained from Merck
(Darmstadt, Germany). I-block was from Tropix (Bedford, MA,
USA). Neutral recombinant mouse CDase was puri¢ed and utilized
to generate rabbit polyclonal antibodies as described in [9]. Rabbit
polyclonal anti-calnexin antibodies were purchased from Stressgen
Biotech (Victoria, BC, Canada). Mouse monoclonal antibodies
against cav-1 and horseradish peroxidase-conjugated anti-mouse and
anti-rabbit IgG1 were from Santa Cruz (Santa Cruz, CA, USA).
2.2. Cell culture
H.end.FB cells were grown in 100 mm dishes in Dulbecco’s modi-
¢ed Eagle medium supplemented with 10% fetal bovine serum and
penicillin G (100 U/ml) plus streptomycin (100 Wg/ml), maintained at
37‡C in a humidi¢ed atmosphere of 5% CO2 and utilized for experi-
ments when 90% con£uent.
2.3. Puri¢cation of cav-enriched membranes
Cells were washed twice with ice-cold PBS, scraped into MES-bu¡-
ered saline (MBS) (25 mM MES, pH 6.5, 0.15 M NaCl, 1% Triton X-
100) containing a mixture of protease inhibitors and homogenized
with a Dounce homogenizer (100 strokes). Lysates were subjected to
sucrose gradient centrifugation essentially as described in [21] with
minor modi¢cations. The homogenate was adjusted to 40% sucrose
by 1:1 addition of 80% sucrose prepared in MBS, placed at the bot-
tom of an ultracentrifuge tube and overlaid with two layers of 30%
and 5% sucrose in MBS. The gradient was then centrifuged at
170 000Ug for 18 h using a Beckman SW50 rotor. For analysis of
the resulting gradient, 0.4 ml fractions were collected from the top of
the gradient. Protein content was quanti¢ed according to the Coo-
massie blue procedure.
2.4. Cholesterol depletion
Cholesterol depletion was carried out according to [22] by incubat-
ing cells with 14 mM CD for 1 h at 37‡C. In some experiments cells
were repleted with cholesterol by incubating them in the presence of
cholesterol/CD mixture (0.2 mM cholesterol and 14 mM CD) for 1 h.
2.5. Lipid analysis
For the determination of SM and Cer levels in sucrose density
fractions, cellular pools were metabolically radiolabeled with
[3H]palmitate (0.7 WCi/ml) for 24 h in the presence of 10 WM unla-
beled palmitate [23]. Under these conditions, sphingolipids were la-
beled well, and palmitate was broken down to acetate and recycled
such that de novo synthesized cholesterol was also labeled. Cell lysates
were then subjected to sucrose gradient fractionation and lipids were
extracted. SM was separated by TLC in a solvent system containing:
chloroform/dimethylketone/methanol/acetic acid/water (60:24:18:
12:6, v/v) [14]. Cer was separated by TLC using chloroform/metha-
nol/ammonia/water (80:20:1:1, v/v) up to 9.5 cm and then with di-
ethyl-ether/methanol (99:1, v/v) up to 19.5 cm [24].
To determine cholesterol distribution in sucrose density fractions,
cells were metabolically radiolabeled with [3H]acetate (10 WCi/ml) for
24 h, in the presence of 10 WM unlabeled acetate [25]. Cell lysates were
then subjected to sucrose gradient fractionation, lipids were extracted
and separated by TLC in a solvent system containing benzene/ethyl-
acetate (60:20, v/v) [26].
2.6. Enzymatic assays
CDase activity was determined using C12-NBD-Cer as a substrate
[27]. Brie£y, 100 pmol of C12-NBD-Cer (NBD-C12:0, d18:1) was
incubated at 37‡C for 2 h with an appropriate amount of protein in
20 Wl of 25 mM Tris^HCl bu¡er, pH 7.5 and 0.25% (w/v) Triton X-
100. Samples were then applied to a TLC plate, which was developed
with chloroform, methanol, 25% ammonia (90:20:0.5, v/v). Spots cor-
responding to NBD-dodecanoic acid and C12-NBD-Cer were scraped,
incubated with methanol at 37‡C to extract the compounds from the
silica and their £uorescence at 470/525 nm excitation/emission wave-
Fig. 1. Sucrose density gradient fractionation of H.end cells. H.end
cell lysates were fractionated by sucrose density gradient centrifuga-
tion. Fractions of 0.4 ml were analyzed for marker proteins cav-1
or calnexin (A), total protein (B), SM and Cer (C) and cholesterol
contents (D). Data of lipid distribution are means þ S.E.M. of a rep-
resentative experiment of at least three performed in triplicate.
When not shown the error bar lies within the symbol.
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lengths was measured. The compounds were quanti¢ed using a stan-
dard curve of known amounts of C12-NBD-Cer and NBD-dodeca-
noic acid.
For the measurement of acid and neutral SMase activities we uti-
lized a spectrophoto£uorimetric assay based on detection of the rate
by which BODIPY FL-Cer was released from BODIPY FL-SM, es-
sentially as previously described [28]. pH values of the enzyme assay
mixture were adjusted to 5.0 and 7.4 for acid and neutral SMase,
respectively.
2.7. Immunoblotting
Protein aliquots from sucrose density gradient fractions were sepa-
rated by SDS^PAGE and then electrotransferred to nitrocellulose
membranes, which were incubated overnight in Tris-bu¡ered saline
containing 0.1% Tween-20 (TTBS) and 0.5% I-block. Hybridization
for 1 h at room temperature with primary antibodies was followed by
washing with TTBS and incubation with peroxidase-conjugated goat
anti-mouse or anti-rabbit IgG1. Proteins were detected by enhanced
chemiluminescence (Amersham Pharmacia Biotech).
2.8. Statistical analysis
The data were analyzed by Student’s t-test and P6 0.05 was con-
sidered signi¢cant. In immunoblot experiments a blot representative
of at least three similar experiments is presented.
3. Results
H.end cells are immortalized cells which maintain the in
vitro features of endothelial cells [29]. In agreement with en-
dothelial phenotype, they were recently shown to be charac-
terized by high levels of cav [30]. To isolate CELMs, in this
study, H.end cells were lysed in the presence of Triton X-100
and fractionated on a discontinuous sucrose density gradient.
The obtained fractions (0.4 ml) were analyzed for cav immu-
noreactivity. As shown in Fig. 1A, cav was enriched in frac-
tions 2^5 (CELMs), which corresponded to the turbid inter-
phasic band between 30 and 5% sucrose equilibrium density.
CELMs excluded the intracellular membrane protein calnexin
which was instead enriched in fractions 10^13. Analysis of
protein pro¢le demonstrated that the bulk of protein was
present in the high density sucrose fractions (Fig. 1B). Typi-
cally CELMs contained a low amount of the total protein
content (1.5 þ 0.6%, n = 9). Distribution of SM and Cer in
the sucrose density fractions was also examined: 64 þ 8%
(n = 4) and 49.7 þ 5% (n = 4) of total labeled SM and Cer,
respectively, were detected in CELMs (Fig. 1C). According
to the high SM content, CELMs were characterized also by
a signi¢cant relative amount of cholesterol (43.7 þ 6% (n = 3)
of the total labeled cholesterol) (Fig. 1D).
On the basis of the data obtained by the analysis of cav and
lipid level distribution, in the subsequent experiments frac-
tions 2^5, 7^9 and 10^13, corresponding to CELMs, inter-
mediate (IM) and high density (HM) membranes, respectively,
were pooled. Distribution of neutral CDase as well as acid
and neutral SMase activities in membrane fractions was then
examined. As it can be observed in Fig. 2A, neutral CDase
was detectable in CELMs; the speci¢c activity of the enzyme
in these microdomains was substantially comparable to that
measured in HMs. In agreement, in CELMs, as well as in the
other fractions, Western analysis of neutral CDase revealed a
band of approximately 94 kDa. In addition, neutral CDase
seems to associate with cav in CELMs since CDase activity
was detectable in anti-cav immunoprecipitates (data not
shown).
Notably, acid (Fig. 2B) and neutral (Fig. 2C) SMase activ-
ities were present in CELMs, both at a higher speci¢c activity
Fig. 2. CDase and SMase activities in sucrose density gradient frac-
tions. Sucrose density gradient fractions corresponding to 2^5
(CELMs), 6^9 (IMs) and 10^13 (HMs) were pooled. Samples were
assayed for neutral CDase activity (A) and subjected to Western
analysis using speci¢c anti-neutral CDase antibodies (A, inset). Re-
combinant mouse liver CDase was used as control. Acid SMase (B)
and neutral SMase (C) activities were also measured. Data are
means þ S.E.M. of a representative experiment of at least three per-
formed in triplicate.
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than that measured in the other membrane fractions. Neutral
SMase activity in CELMs was not activated by the addition
of MgCl2 to the enzyme assay mixture (42.6 þ 6.3 and
48.2 þ 5.1 pmol/Wg/h in the absence or presence of 10 mM
MgCl2, respectively (n = 3)), suggesting that a Mg2-indepen-
dent isoform is located in these microdomains.
Cell treatment with CD has been successfully utilized in
various instances to deplete cholesterol. As reported in Fig.
3, incubation of H.end cells for 1 h with 14 mM CD e⁄ciently
removed cholesterol from membranes. Cholesterol depletion
was responsible also for a profound redistribution of the cav-
eolae marker cav, which was detectable in all gradient frac-
tions (Fig. 3A). Remarkably, a signi¢cant rise in neutral
CDase activity in light membranes and IMs was observed in
CD-treated cells (Fig. 3C), suggesting a negative role of cho-
lesterol in CDase regulation. Consistently, in HMs, where
Fig. 3. E¡ect of cholesterol depletion on cav distribution, CDase and SMase activities. Con£uent H.end cells were treated with 14 mM CD for
1 h and processed for sucrose density gradient fractionation. Samples of each fraction from control (3) and CD-treated (+) cells were analyzed
for the presence of cav (A). Cholesterol content (B), neutral CDase (C), acid (D) and neutral (E) SMase activities were also measured in con-
trol and CD-treated cells. Data are means þ S.E.M. of a representative experiment of three performed in triplicate. When not shown the error
bar lies within the column.
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cholesterol levels were not a¡ected by CD treatment, no sig-
ni¢cant variation of CDase activity was detected. On the con-
trary, neither neutral nor acid SMase activity was a¡ected by
cholesterol depletion (Fig. 3D,E), indicating a di¡erential sen-
sitivity of murine endothelial cell CDase and SMase activities
to cholesterol.
4. Discussion
In this report we have shown that CELMs from murine
endothelial cells, enriched in SM, Cer and cholesterol, bear
neutral and acid SMase activities as well as neutral CDase,
suggesting that in these microdomains active SM metabolism
can take place. Acid SMase was already described in light
detergent-insoluble membranes [14] and more recently neutral
and acid SMase activities were found associated to these mi-
crodomains [18].
In this study evidence is presented that also CELMs ob-
tained from H.end endothelial cells contain acid and neutral
SMase activities. However, di¡erently from what is observed
in sphingolipid-enriched microdomains of human ¢broblasts
[18], neutral SMase localized in CELMs of endothelial cells
resulted to be Mg2-independent, suggesting that a distinct
SMase isoform is present. This hypothesis is further supported
by the di¡erent sensitivity to cholesterol depletion of neutral
SMase activity in the two cell systems, given that endothelial
neutral SMase localized in membrane fractions, in disagree-
ment with ¢broblast SMase [18], was not a¡ected by treat-
ment with CD.
Here is reported for the ¢rst time that neutral CDase is
localized in CELMs of endothelial cells. Of note, CDase
was found distributed among sucrose density fractions di¡er-
ently from acid and neutral SMase activities. Indeed, speci¢c
activity of CDase in CELMs was comparable to that detected
in HMs, whereas speci¢c activities of neutral and acid SMase
were by far higher than those of the other fractions.
The identi¢cation of CDase in CELMs adds a new piece of
information to the comprehension of subcellular distribution
of CDases. Indeed, overexpressed human neutral CDase was
detected in mitochondria of MCF7 and HEK293 cells [8],
more recently immuno£uorescence studies identi¢ed mouse
liver neutral CDase mainly in late endosomes/lysosomes while
rat kidney neutral CDase resulted to be almost exclusively in
lipid rafts of apical membranes [9]. Endothelial cell neutral
CDase was almost completely solubilized by freeze-thawing
(Romiti et al., unpublished results), similarly to what was
observed for mouse liver enzyme [31], thus suggesting that
the bulk of the enzyme is located in intracellular vesicles. In
agreement with this hypothesis, H.end cells actively release
neutral CDase in the medium [27]. The identi¢cation of neu-
tral CDase in CELMs is not in disagreement with a mainly
vesicular membrane localization of the enzyme in endothelial
cells, given that proteins located in CELMs represented less
than 2% of total cell protein. Another interesting ¢nding of
this study is represented by the large stimulatory e¡ect exerted
by cholesterol depletion on CDase activity. Cholesterol deple-
tion is known to alter caveolar structure [12] and this exper-
imental approach has been utilized in several instances to
ascribe eventual observed phenomena to destruction of mem-
brane microdomains and/or to prove speci¢c interaction with
the caveolae sca¡olding protein cav. Here we provided exper-
imental evidence that cholesterol depletion of H.end cells was
indeed responsible for a redistribution of cav throughout the
sucrose gradient fractions, as also observed in other experi-
mental settings [32]. However, the ¢nding that CDase activity
was signi¢cantly increased by cholesterol depletion also in
IMs, where CD treatment increased cav content, is consistent
with a speci¢c regulatory role of CDase exerted by cholester-
ol. The importance of this newly discovered CDase regulatory
mechanism for the maintaining and fate of caveolae, known
to be involved in cell cholesterol e¥ux in this cell type [33],
remains to be established, although it is suggestive to specu-
late that CDase may have a role in lipid remodeling subse-
quently to cholesterol delivery by caveolae.
In addition to a possible role of caveolar neutral CDase in
the dynamics of these microdomains, participation of the en-
zyme in signaling events compartmentalized in caveolae can
also be postulated. Since neutral CDase is known to be up-
regulated by extracellular ligands, such as platelet growth fac-
tor [34], it will be of interest to investigate whether caveolar
CDase activity is agonist-regulated given that an important
role of caveolar Cer has already been proved in the control
of the phosphatidylinositol 3-kinase survival pathway [35].
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